The Pain Perception Threshold in Attention Deficit Disorder With Hyperactivity
Can the Disease Subtype Affect the Pain Perception Threshold in Children Diagnosed With Attention Deficit Disorder With Hyperactivity?
1 other identifier
observational
84
1 country
1
Brief Summary
The aim of this study was to evaluate whether the disease subtype affects the presence of chronic pain and pain perception threshold in pediatric patients followed up with the diagnosis of attention deficit and hyperactivity disorder, and to evaluate the factors that may be related to pain perception threshold in disease subtypes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2025
CompletedFirst Posted
Study publicly available on registry
February 13, 2025
CompletedStudy Start
First participant enrolled
February 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2025
CompletedDecember 30, 2025
December 1, 2025
10 months
February 7, 2025
December 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
pressure pain threshold
The pressure pain threshold will be assessed with a manual pressure algometer (Baseline Dolorimtre®). The patients' pain perception thresholds will be measured bilaterally in the midfrontal region, the midpoint of the trapezius muscle, the lateral epicondyle, the midpoint of the web between the 1st and 2nd fingers, the greater trochanter, and the medial crease of the knee. During the measurement, the 1.52 cm2 flat circular probe of the algometer will be placed on the relevant area and the pressure will be increased by 1 kg/second. Patients will be asked to express their pain by saying 'stop' or raising their hands when they feel slight discomfort. The value for each reference area will be obtained by calculating the arithmetic mean of the paired measurements.
Baseline
Secondary Outcomes (5)
Presence of chronic pain
Baseline
Pain score
Baseline
Duration of chronic pain
Baseline
Sociodemographic data of patient
Baseline
Sociodemographic data of patient's parents
Baseline
Study Arms (3)
Predominantly Inattentive
Patients diagnosed with inattentive subtype of attention deficit disorder with hyperactivity according to DSM-5 diagnostic criteria.
Predominantly Hyperactive-Impulsive
Patients diagnosed with hyperactive-impulsive subtype of attention deficit disorder with hyperactivity according to DSM-5 diagnostic criteria.
Inattentive and Hyperactive-Impulsive Combination
Patients diagnosed with mix subtype of attention deficit disorder with hyperactivity according to DSM-5 diagnostic criteria.
Interventions
The patients' pressure pain threshold will be evaluated with a manual pressure algometer (Baseline Dolorimtre®).The patients' pain perception thresholds will be measured bilaterally in the midfrontal region, the midpoint of the trapezius muscle, the lateral epicondyle, the midpoint of the web between the 1st and 2nd fingers, the greater trochanter, and the medial crease of the knee.
Eligibility Criteria
Patients will be selected from among those who apply to Edirne Sultan 1. Murat State Hospital Child and Adolescent Mental Health and Diseases polyclinic.
You may qualify if:
- Diagnosed with attention deficit and hyperactivity disorder according to DSM-5 diagnostic criteria
- Being between the ages of 6-17
- Being at a clinically normal mental level
You may not qualify if:
- Having verbal and visual communication problems
- Having a history of perinatal complications or physical head trauma
- Having comorbid psychiatric disorders other than oppositional defiant disorder and conduct disorder
- Known history of chronic physical and neurological disease (such as cerebral palsy, diabetes, epilepsy, autoimmune diseases, liver and kidney failure)
- Presence of substance or alcohol use disorder
- Having a genetic disorder diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sultan 1. Murat State Hospital
Edirne, 22030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
İbrahim Tiryaki, MD
Sultan 1. Murat State Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 7, 2025
First Posted
February 13, 2025
Study Start
February 16, 2025
Primary Completion
December 26, 2025
Study Completion
December 26, 2025
Last Updated
December 30, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
If requested, the data of the study will be shared by the researchers.